影响EGFR不可逆转抑制的因素和奇拉性对共价结合的影响
Pasquale A Morese1, Ayaz Ahmad2, Mathew P Martin3
1Cancer Research Horizons Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Bedson Building, Newcastle University, Newcastle upon Tyne, UK.
Communications chemistry
|April 9, 2025
概括
向的共价抑制剂对于药物发现至关重要. 一种新的测定方法有效地测量了非共价亲和力,弹头反应力和几何学,有助于开发有力的候选药物.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 化学生物学 化学生物学
背景情况:
- 向共价抑制剂 (TCI) 在药物发现中越来越重要.
- 优化TCI功率需要平衡弹头反应性,几何和非共价相互作用.
- 在实践测试级联中剖析这些因素的既定方法缺乏.
研究的目的:
- 调查表皮生长因子受体 (EGFR) 抑制剂类型的结构-反应-活性关系.
- 开发和验证用于评估TCI发展因素的务实试验.
- 了解结构修改如何影响非共价亲和力,弹头反应性和几何.
主要方法:
- 合成了一系列具有系统结构修改的波齐奥提尼布类似物.
- 在模拟系列中,弹头的反应能力和几何形状各不相同.
- 采用调整的探头位移试验来评估非共价亲和力和反应性.
- 利用X射线晶体学和计算研究进行结构合理化.
- 进行了细胞机理学和表型分析,以确认功能影响.
主要成果:
- 一个简单的,调整的探测器位移试验可以解非共价亲和力,弹头反应力和几何学的影响.
- 结构变化显著影响了这三个因素,影响了整体效能.
- 该试验检测出异构体之间的实质性强度差异,与共价结合能力相关.
- X射线晶体学和计算建模为观察到的差异提供了结构性的洞察力.
- 观察到的效应量化转化为细胞活动.
结论:
- 实用探针位移测定对于评估TCI发展的关键因素是有效的.
- 了解结构-反应性-活性关系对于设计强效和选择性共价抑制剂至关重要.
- 这种方法通过剖析对功效的贡献,促进了对共价药物的合理设计.
- 这些发现为优化TCI发现和开发级联提供了一个框架.
相关概念视频
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
164
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
164
Chirality in Nature
12.6K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
12.6K
Allosteric Regulation
57.4K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
506
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
506


